Software Application Designed to Process Digitized Screen-Film Mammograms

New software is the only U.S. Food and Drug Administration- (FDA)-cleared application intended to process digitized screen-film mammograms for comparison purposes. The product is now available worldwide.

Hologic, Inc. (Bedford, MA, USA), a developer, manufacturer, and supplier of diagnostics, medical imaging systems, and surgical products geared to serving the healthcare needs of women, announced that it has received Food and Drug Administration (FDA) clearance for its R2 DigitalNow HD software application.

By collaborating with radiologists to understand the demands of reading digital mammograms, Hologic created the R2 DigitalNow HD software, which adapts each digitized film image to a selected contrast and tissue intensity that models a digital mammography system. It also embeds a series of look-up tables in the image that allow Integrated Healthcare Enterprise (IHE) mammography conformant workstations to draw out less evident regions of density within digitized films. The IHE Mammo profile defines the necessary mammography requirements for the display quality, behavior, layout, and annotation of prior and current mammography image for diagnostic workstations.

"The DigitalNow HD software is designed to enhance workflow by promoting consistency in the digital mammography reading environment,” said Julian Marshall, director, R2 product management and principal engineer at Hologic. "One of the most powerful capabilities of this product is that images already digitized by R2 DigitalNow software and stored in PACS [picture archiving and communication system] can be routed to R2 DigitalNow HD and reprocessed.”

Related Links:
Hologic